| |
|
|
LIUYANG, CHINA - The Hunan Provincial Government is partnering with Microbix Biosystems to construct an influenza vaccine manufacturing complex in the Hunan Liuyang Biomedical Industrial Park in China. The $200-million jointly-owned project, one of the largest flu vaccine production facilities worldwide, will be managed by Microbix and will utilize the company’s VIRUSMAX technology.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more!
Sign Up Now!
|
|